DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 802 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $859,000 | +0.8% | 8,705 | 0.0% | 0.08% | -2.3% |
Q1 2018 | $852,000 | +5.4% | 8,705 | 0.0% | 0.09% | +4.8% |
Q4 2017 | $808,000 | +8.2% | 8,705 | 0.0% | 0.08% | -17.8% |
Q3 2017 | $747,000 | +1.6% | 8,705 | 0.0% | 0.10% | -6.5% |
Q2 2017 | $735,000 | -57.7% | 8,705 | -57.1% | 0.11% | -59.7% |
Q1 2017 | $1,737,000 | +28.3% | 20,305 | +16.7% | 0.27% | +7.6% |
Q4 2016 | $1,354,000 | +41.6% | 17,400 | +42.6% | 0.25% | -9.5% |
Q3 2016 | $956,000 | -24.9% | 12,200 | -3.2% | 0.28% | -14.3% |
Q2 2016 | $1,273,000 | +6.5% | 12,600 | 0.0% | 0.32% | +3.5% |
Q1 2016 | $1,195,000 | -4.0% | 12,600 | -6.0% | 0.31% | -1.3% |
Q4 2015 | $1,245,000 | +9.0% | 13,400 | 0.0% | 0.31% | +1.9% |
Q3 2015 | $1,142,000 | +8.5% | 13,400 | +8.9% | 0.31% | +23.7% |
Q2 2015 | $1,053,000 | +12.7% | 12,300 | +11.8% | 0.25% | +10.2% |
Q1 2015 | $934,000 | +109.4% | 11,000 | +111.5% | 0.23% | +78.0% |
Q4 2014 | $446,000 | +54.3% | 5,200 | +36.8% | 0.13% | +54.9% |
Q3 2014 | $289,000 | -30.7% | 3,800 | -28.3% | 0.08% | -18.8% |
Q2 2014 | $417,000 | -9.0% | 5,300 | -13.1% | 0.10% | -12.2% |
Q1 2014 | $458,000 | +6.0% | 6,100 | +8.9% | 0.12% | +1.8% |
Q4 2013 | $432,000 | +11.3% | 5,600 | 0.0% | 0.11% | +2.7% |
Q3 2013 | $388,000 | +9.6% | 5,600 | 0.0% | 0.11% | +6.8% |
Q2 2013 | $354,000 | – | 5,600 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |